AAAAAA

   
Results: 1-13 |
Results: 13
Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology
Authors: Eikenboom, JCJ
Citation: Jcj. Eikenboom, Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology, BEST P R C, 14(2), 2001, pp. 365-379
Elevated factor VIII levels and the risk of thrombosis
Authors: Kamphuisen, PW Eikenboom, JCJ Bertina, RM
Citation: Pw. Kamphuisen et al., Elevated factor VIII levels and the risk of thrombosis, ART THROM V, 21(5), 2001, pp. 731-738
A standard nomenclature for von Willebrand factor gene mutations and polymorphisms
Authors: Goodeve, AC Eikenboom, JCJ Ginsburg, D Hilbert, L Mazurier, C Peake, IR Sadler, JE Rodeghiero, F
Citation: Ac. Goodeve et al., A standard nomenclature for von Willebrand factor gene mutations and polymorphisms, THROMB HAEM, 85(5), 2001, pp. 929-931
High factor VIII antigen levels increase the risk of venous thrombosis butare not associated with polymorphisms in the von Willebrand factor and factor VIII gene
Authors: Kamphuisen, PW Eikenboom, JCJ Rosendaal, FR Koster, T Blann, AD Vos, HL Bertina, RM
Citation: Pw. Kamphuisen et al., High factor VIII antigen levels increase the risk of venous thrombosis butare not associated with polymorphisms in the von Willebrand factor and factor VIII gene, BR J HAEM, 115(1), 2001, pp. 156-158
Type I von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins
Authors: Bodo, I Katsumi, A Tuley, EA Eikenboom, JCJ Dong, ZY Sadler, JE
Citation: I. Bodo et al., Type I von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins, BLOOD, 98(10), 2001, pp. 2973-2979
Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels
Authors: Kamphuisen, PW Rosendaal, FR Eikenboom, JCJ Bos, R Bertina, RM
Citation: Pw. Kamphuisen et al., Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels, ART THROM V, 20(5), 2000, pp. 1382-1386
Grossly abnormal proteolysis of von Willebrand factor (VWF) in a patient heterozygous for a gene deletion and mutation in the dimerization area of VWF
Authors: Castaman, G Eikenboom, JCJ Lattuada, A Rodeghiero, F
Citation: G. Castaman et al., Grossly abnormal proteolysis of von Willebrand factor (VWF) in a patient heterozygous for a gene deletion and mutation in the dimerization area of VWF, THROMB HAEM, 84(4), 2000, pp. 729-730
Pregnancy in women with type T von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F
Authors: Castaman, G Eikenboom, JCJ Contri, A Rodeghiero, F
Citation: G. Castaman et al., Pregnancy in women with type T von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F, THROMB HAEM, 84(2), 2000, pp. 351-352
Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia
Authors: Kamphuisen, PW Lensen, R Houwing-Duistermaat, JJ Eikenboom, JCJ Harvey, M Bertina, RM Rosendaal, FR
Citation: Pw. Kamphuisen et al., Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia, BR J HAEM, 109(3), 2000, pp. 519-522
Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect
Authors: Castaman, G Eikenboom, JCJ Missiaglia, E Rodeghiero, F
Citation: G. Castaman et al., Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect, BR J HAEM, 108(4), 2000, pp. 876-879
Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation
Authors: Castaman, G Eikenboom, JCJ Lattuada, A Mannucci, PM Rodeghiero, F
Citation: G. Castaman et al., Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation, BR J HAEM, 108(1), 2000, pp. 188-190
Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation
Authors: Castaman, G Eikenboom, JCJ Bertina, RM Rodeghiero, F
Citation: G. Castaman et al., Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation, THROMB HAEM, 82(3), 1999, pp. 1065-1070
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions
Authors: Kamphuisen, PW Eikenboom, JCJ Vos, HL Pablo, R Sturk, A Bertina, RM Rosendaal, FR
Citation: Pw. Kamphuisen et al., Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions, THROMB HAEM, 81(5), 1999, pp. 680-683
Risultati: 1-13 |